[EN] RET INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF<br/>[FR] INHIBITEURS DE RET, COMPOSITIONS PHARMACEUTIQUES ET UTILISATIONS ASSOCIÉES
申请人:SUNSHINE LAKE PHARMA CO LTD
公开号:WO2020114494A1
公开(公告)日:2020-06-11
Provided herein are a RET inhibitor, a pharmaceutical composition thereof and uses thereof. In particular, provided is a compound having Formula (I) or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof. Provided is a pharmaceutical composition comprising the compound, and uses of the compound and pharmaceutical composition thereof for the preparation of a medicament, in particular for treatment and prevention of RET-related diseases and conditions, including cancer, irritable bowel syndrome, and/or pain associated with irritable bowel syndrome.
本文提供了一种RET抑制剂,其药物组合物及用途。具体而言,提供了具有化学式(I)或其立体异构体、几何异构体、互变异构体、N-氧化物、溶剂合物、代谢物、药用可接受的盐或其前药的化合物。提供了包含该化合物的药物组合物,并提供了该化合物及其药物组合物的用途,用于制备药物,特别是用于治疗和预防与RET相关的疾病和症状,包括癌症、肠易激综合征以及与肠易激综合征相关的疼痛。